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Abstract
G proteins are an important family of signalling molecules controlled by guanine nucleotide
exchange and GTPase activity in what is commonly called an ‘activation/inactivation cycle’.
The molecular mechanism by which guanine nucleotide exchange factors (GEFs) catalyse
the activation of monomeric G proteins is well-established, however the complete reversibil-
ity of this mechanism is often overlooked. Here, we use a theoretical approach to prove that
GEFs are unable to positively control G protein systems at steady-state in the absence of
GTPase activity. Instead, positive regulation of G proteins must be seen as a product of the
competition between guanine nucleotide exchange and GTPase activity—emphasising a
central role for GTPase activity beyond merely signal termination. We conclude that a more
accurate description of the regulation of G proteins via these processes is as a ‘balance/
imbalance’mechanism. This result has implications for the understanding of intracellular
signalling processes, and for experimental strategies that rely on modulating G protein
systems.
Introduction
G proteins are an important and universal family of intracellular signalling molecules, incorpo-
rating both the alpha subunits of heterotrimeric G proteins and the Ras small monomeric G
proteins. Most G proteins bind guanine nucleotides (GDP, GTP) in a strongly conserved nucle-
otide binding pocket—an ancient mechanism preserved in both eukaryotes and prokaryotes
[1–3]. Typically, G proteins transition between two discrete conformations with distinct signal-
ling functions depending on which nucleotide is bound, and so G proteins are often referred to
as ‘molecular switches’. G protein regulatory systems are crucial components of many intracel-
lular processes and incorrect regulation of G proteins has been implicated in disease: cancer
[4–6], cardiovascular disease [7], genetic disorders [8], among many others.
Regulation of G protein activation state is largely controlled by two mechanisms (Fig 1A)
and is commonly described as an ‘activation/inactivation cycle’ between the GTP-bound ‘on/
active’ state and the GDP-bound ‘off/inactive’ state [9, 10]. Activation of G proteins is enabled
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by accessory proteins which catalyse guanine nucleotide exchange—the sequential release of
GDP and binding of GTP. For monomeric G proteins these are known as guanine nucleotide
exchange factors (GEFs). For heterotrimeric G proteins, G protein coupled receptors (GPCRs)
fulfil this role. Inactivation of G proteins is controlled by GTPase activity which may either be
intrinsic, or be provided via accessory GTPase-activating proteins (GAPs). It is generally
thought that GTPase activity is required for the termination of G protein signalling but that it
is not essential for signal transmission [11].
An often overlooked property of GEFs is that their catalytic mechanism is completely
reversible (Fig 1B) [12]. GEF-binding is not specific to GDP-bound G protein—GEFs can also
bind to GTP-bound G protein and catalyse the reverse nucleotide exchange, GTP to GDP. In
this way GEFs are capable of inactivating G proteins [13]. The extent to which the reversibility
of this mechanism has been overlooked is demonstrated by the sheer number of publications
which include diagrams where arrows corresponding to GEF-mediated regulation are drawn as
unidirectional—missing the reverse arrowhead highlighted in Fig 1A. This error is perhaps
best illustrated by its occurrence in core biology textbooks, for example:
• Figures 3–66 and 3–68 in [14]
• Figures 16–15 and 16–16 in [15]
• Figure 4, box 12–2 in [16]
Fig 1. The activation of G proteins is regulated by GEFs and GTPase activity. AG proteins are
controlled by GEFs which catalyse the sequential release and binding of guanine nucleotides, and by
GTPase activity (both intrinsic and GAP-mediated) which hydrolyses bound GTP to form GDP and Pi. The
red circle highlights that the GEFmechanism is completely reversible. B The reversible mechanism by which
a GEF catalyses guanine nucleotide exchange on a G protein proceeds through a series of GEFG protein
complexes [13]. Parameters ki are kinetic rates which are unique to each G protein:GEF system. Associated
species (free GEF, GTP, GDP) have not been drawn. The thick black arrow identifies forwards nucleotide
exchange, catalysing the activation of the G protein. The thick red arrow identifies reverse nucleotide
exchange, catalysing the inactivation of the G protein.
doi:10.1371/journal.pone.0151861.g001
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• Figure 13.40 in [17]
• Figure 19–40 in [18]
• Figure 7.12A in [19]
• Figure 10.3 and 10.4 in [20]
• Figure 42.4 in [21]
There has been recent renewed interest in understanding the roles and functions of GEFs
based on a proper consideration of their thermodynamics and enzyme kinetics [12, 22, 23].
Additionally, G protein:GEF interactions have previously been thoroughly studied in the con-
text of thermodynamics [24]. Here we develop the existing theoretical understanding of G pro-
tein regulation by GEFs and GTPase activity through further exploring the consequences of the
reversibility of the GEF mechanism. We use mathematical methods to investigate a set of
generic and minimal G protein regulatory systems independent of measured kinetic rates, in
the context of the physiologically important steady-state dynamics. This allows us to comment
and draw conclusions on the qualitative behaviours of similar G protein:GEF:GTPase systems
under a wide variety of conditions. These minimal systems consist of a single G protein, a sin-
gle GEF, and either intrinsic or GAP-mediated GTPase activity, with no external influences or
localisation effects, and under the assumption that the system is homogeneous in space. For
illustrative purposes, to ensure that the included figures are physiologically plausible, our simu-
lations use parameters described for the Ran:RCC1:RanGAP1 system [25, 26]—chosen as this
provides a complete set of rate constants for the G protein:GEF interaction (as described in Fig
1B) and corresponding Michaelis-Menten constants for the G protein:GAP interaction.
Results
Qualitative differences between reversible and irreversible mechanisms
To demonstrate the qualitative difference between a reversible and an irreversible mechanism
we derived mass-action models of the GEF mechanism (Fig 1B, Methods) and an artificial irre-
versible mechanism generated by disallowing release of GTP from the GEFG protein complex.
The reversible and irreversible models were simulated: in the absence of GTPase activity
(Fig 2A and 2D); with intrinsic GTPase activity, modelled by exponential decay (Fig 2B and
2E); and with GAP-mediated GTPase activity, modelled using the Michaelis-Menten equation
(Fig 2C and 2F).
In the presence of either form of GTPase activity both reversible and irreversible mecha-
nisms display qualitatively similar behaviour (ignoring differences in magnitude) which is con-
sistent with observations of GEF-mediated activation of G proteins in a wide range of
biological systems [27–31].
In the absence of GTPase activity we see a qualitative difference in the behaviour of the two
mechanisms—each distinct from their shared behaviour in the presence of GTPase activity.
While both mechanisms show an inhibitory effect (which will be discussed below in more
detail for the GEF mechanism), the steady-state concentrations of active and inactive G protein
differ substantially. This demonstrates how the assumption of an irreversible model could pos-
sibly lead to incorrect conclusions, at least when considering extremal (i.e. diseased) states.
GEFs act to attain a constant ratio of inactive to active G protein
We derived a simplified quasi-steady-state model of the GEF mechanism (Fig 1B) in an equiva-
lent manner to the derivation of the Michaelis-Menten equation [32–35]. This quasi-steady-
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state model captures the behaviour of a generic and minimal G protein regulatory system in a
single equation:
d½GGTP
dt
¼ kfwdð½GGDP  k½GGTPÞe0
K0 þ K1½GGDP þ K2½GGTP
 fGTPase
Here [GGXP] is the concentration of GXP-bound G protein and κ is the ratio of the back-
wards to the forwards kinetic rates. (For definitions of the other parameters see the Methods
section.)
At steady-state (setting the above equation equal to zero), in the absence of GTPase activity,
we find that the ratio of inactive to active G protein must always equal the value of the constant
κ. An equivalent statement is: GEFs act to produce a constant proportion of active G protein.
While the ratio of inactive to active G protein (κ) and proportion of active G protein ( 1kþ1) will
vary for different G protein:GEF systems, these values will remain constant within a system,
independent of the G protein or GEF concentrations.
GEFs can be inhibitory
The commonly used description of GEFs as ‘activators’ of G proteins is contradicted by the
inhibitory effect seen when the GEF mechanism is simulated in the absence of GTPase activity
(Fig 2D).
The inhibitory effect can be explained by an equivalent increase in the concentrations of
intermediate GEFG protein complexes. Values for the concentrations of these intermediate
Fig 2. Apparent activation of G proteins via GEFs is only observed when GTPase activity is present. Simulation of mass-action models, see Methods.
GGXP denotes GXP-bound G protein. The shaded region denotes stimulation of the system by increasing the active GEF 10-fold from its basal concentration.
For all simulations, steady-state concentrations were used as the initial conditions. Mass corresponding to GEFG protein complexes has not been drawn. A,
B, C An artificial irreversible model, constructed by assuming the rate of release of GTP from the active GEFG protein complex is zero. D, E, F The reversible
GEFmechanism (Fig 1B).
doi:10.1371/journal.pone.0151861.g002
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complexes were derived as part of the construction of the quasi-steady-state model. Using
these values, we obtained an equation for the proportion of (free) active G protein in terms of
the total concentration of GEF. This equation is plotted in Fig 3A. Mathematically, we are then
able to prove that in the absence of GTPase activity the concentration of active G protein is
inversely related to the total concentration of GEF. As the concentration of GEF increases, the
concentration of active G protein will always decrease, and vice-versa.
Note that a high concentration of GEF will also lead to a faster total catalytic rate (a larger
Vmax). This suggests that there will be a tradeoff in terms of increasing the concentration of
GEF: a low concentration of GEF means that there will be little inhibition, but a slow total rate;
a high concentration of GEF will lead to inhibition, but a fast total rate. We therefore hypothe-
sise that for a healthy G protein system, the concentration of GEF will lie in a physiologically
relevant region, where the inhibitory effect is not so pronounced, but where there is still suffi-
cient GEF to catalyse nucleotide exchange at an appropriate rate.
GTPase activity has a functional role in the observed activation of G
proteins
The simulations of the GEF mechanism show that inclusion of GTPase activity is sufficient to
restore an apparent GEF-mediated activation (Fig 2E and 2F). By comparing these with the
simulation of the system without GTPase activity (Fig 2D) we can see how this activation
arises. Initially, due to the GTPase activity, the activation state reached by the system is sup-
pressed—it is much reduced from the maximum proportion of active G protein achieved in the
absence of GTPase activity. An increase in the concentration of GEF is then able to positively
regulate the system by moving the activation state closer to that maximum. For intrinsic
GTPase activity we obtained an equation which describes the effect of the relative rates of GEF-
catalysed nucleotide exchange and GTPase activity on the proportion of G protein which is
active. This equation is plotted in Fig 3B, where we see a sigmoidal response—increasing the
concentration of GEF (relative to the GTPase activity) increases the concentration of active G
protein. Again this allows us to hypothesise that, for a healthy G protein system, the relative
rates of nucleotide exchange and GTPase activity must lie in this sigmoidal region, in order for
the system to properly respond to an activating or inhibitory signal.
Fig 3. GTPase activity restores the ability of GEFs to positively regulate a G protein bymoving the system away from equilibrium. The relationship
between the concentration of GEF and the steady-state proportion of active G protein. The concentration of active G protein cannot increase above a
theoretical maximum proportion derived from the ratio of the total backwards and forwards catalytic rates of the GEF (κ). The markers and arrow demonstrate
the effect seen before (circle) and during (square) the stimulation shown in Fig 2D and 2E. The shaded region denotes the region which is most likely to be
physiologically relevant. A In the absence of GTPase activity, Eq 5, increasing the GEF concentration can only decrease the steady-state concentration of
active G protein, instead producing GEFG protein complexes. B In the presence of GTPase activity, Eq 7, the steady-state concentration of active G protein
is suppressed. Increasing the (relative) concentration of GEF acts to counter this suppression, driving the activation state back towards the maximum.
doi:10.1371/journal.pone.0151861.g003
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Together, this demonstrates a requirement for GTPase activity for the observable activation
of G proteins by GEFs, at least within a minimal G protein regulatory system. The proposed
mechanism of regulation for such a G protein:GEF:GTPase system can be summarised as fol-
lows: 1. GTPase activity inactivates the G protein system by altering the ratio of inactive to
active G protein away from a GEF-mediated equilibrium. 2. If the rate of guanine nucleotide
exchange increases, or the GTPase activity decreases, the proportion of active G protein will
then move towards the GEF-mediated equilibrium, activating the system. We note that our
result can be described in lay terms as: ‘G proteins must be first turned off, before they can be
turned on’.
Discussion
We have shown that there are certain properties of GEF-mediated regulation of G proteins that
arise from the reversibility of its mechanism and which are independent of specific kinetic
rates. The complete reversibility of the GEF mechanism means that at steady-state any GEF
acts to produce a constant ratio of inactive to active G protein—giving a theoretical maximum
proportion of active G protein. Once this maximum is attained, then any subsequent increase
in the concentration of GEF—the ‘activator’ of the system—cannot increase the concentration
of active G protein. Instead we will observe inhibition caused by creation of excess intermediate
GEFG protein complexes.
We urge caution against the naïve description of GEFs as ‘enzymes that activate G proteins’
and against representations that show this mechanism as irreversible, as we have shown how
these shorthands can distort our understanding of the underlying biology. We would instead
suggest that GEFs are thought of as enzymes that act to attain an equilibrium—a balance—of
active and inactive G protein—a definition which is entirely consistent with their existing des-
ignation as ‘exchange factors’. Correspondingly, we see GTPase activity as having two main
roles: to drive the system away from this equilibrium—to create an imbalance—and so permit
positive regulation by GEFs; and to confer a unique directionality on the G protein regulatory
‘cycle’. Therefore we propose that G protein signalling, at least in its minimal form discussed
here, is better described as operating through ‘regulated balance/imbalance’.
Both the complete reversibility of guanine nucleotide exchange and associated requirement
for GTPase activity as a functional component in the activation of G proteins has previously
been under-appreciated. This may be due to the almost exclusive use of experimental systems
where the GDP form of the G protein is the unique starting condition and where uptake of
GTP is monitored as the GEF assay. We also note that our simulations show that an artificial
irreversible mechanism (Fig 2B and 2C) and reversible GEF mechanism (Fig 2E and 2F) have
similar profiles in the presence of GTPase activity and so under many conditions it may be dif-
ficult to experimentally distinguish these mechanisms.
We predict that experimental protocols which attempt to regulate G proteins by the over-
expression of a GEF are likely to produce unexpected behaviour. We expect that in many cases
this may cause inhibition of the G protein rather than activation (Fig 3A). Activation of G pro-
teins should therefore be preferentially targeted by reduction of the relevant GTPase activity
(Fig 3B). Note that these results remain consistent with the long-established use of dominant
negative mutants for the inhibition of G protein systems [36, 37]. We accept that many previ-
ous studies that have ignored the reversibility of GEFs will have made conclusions that are
valid under many conditions. But we stress that in extremal scenarios (such as in disease) those
conclusions may not always hold.
Additionally, we hope that this new perspective in considering the control of G proteins will
lead to novel approaches for the control of G protein systems. GEFs have previously been
Activation of G Proteins by GEFs Relies on GTPase Activity
PLOS ONE | DOI:10.1371/journal.pone.0151861 March 17, 2016 6 / 12
suggested as potential therapeutic targets [13]. Our results extend this to a novel, and seemingly
paradoxical, mechanism by which over-expression of an activator could lead to the inhibition
of its substrate. This may have implications in G protein systems with diminished GTPase
activity, for example constitutively active transforming mutations in Ras common in cancers
[38], where additional GAP activity would have no effect but where sequestration of active G
protein by a GEF may be useful alternative.
It is important to note that our mathematical results explicitly apply to the system we have
considered: a homogeneous system with deterministic kinetics with no localisation or other
external interactions, and under the reasonable assumption that the majority of its functional
signalling is due to the steady-state behaviour. The precise equilibrium ratios, total rates, and
inhibitory effects for any system that follows these requirements will depend on the specific
kinetic rates for the GEF and the strength of GTPase activity, but the overall qualitative charac-
teristics should remain consistent. Conclusions based on alternative mechanisms would
require further analysis, for instance systems with an implicit G proteinGEFGAP complex
[39], or systems with changes in localisation, for example reversible membrane-tethering of
Arf during activation [40]. While we certainly accept that some additional complications may
alter the behaviour of specific G protein:GEF:GTPase systems, we suggest that, rather than
speculation, these modified systems have their own behaviours analysed mathematically.
Methods
The following mathematical analysis uses the notation:
• G protein without nucleotide bound! G
• G protein with GDP bound! GGDP
• G protein with GTP bound! GGTP
• GEF! E
The volume concentration of a species S will be denoted by [S].
Mass-action model
A deterministic ordinary differential equation (ODE) model of the GEF mechanism (Fig 1B)
was derived using the law of mass-action:
d½E
dt
¼ ½Eðk1½GGDP þ k5½GGTPÞ þ k2½E  GGDP þ k6½E  GGTP
d½E  GGDP
dt
¼ ðk2 þ k3Þ½E  GGDP þ k1½GGDP½E þ k4½E  G½GDP
d½E  GGTP
dt
¼ ðk6 þ k7Þ½E  GGTP þ k5½GGTP½E þ k8½E  G½GTP
d½E  G
dt
¼ ðk4½GDP þ k8½GTPÞ½E  G þ k3½E  GGDP þ k7½E  GGTP
d½GGDP
dt
¼ k1½E½GGDP þ k2½E  GGDP þ fGTPase
d½GGTP
dt
¼ k5½E½GGTP þ k6½E  GGTP  fGTPase
Activation of G Proteins by GEFs Relies on GTPase Activity
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We assume: for systems with no GTPase activity, fGTPase = 0; for systems with intrinsic
GTPase activity, fGTPase = kase[GGTP]; and for systems with GAP-mediated GTPase activity,
fGTPase ¼ kase ½GGTP f0Kmþ½GGTP  where f0 is the total concentration of GAP.
There is an equation for the conservation of mass of GEF:
e0 ¼ ½E þ ½E  GGDP þ ½E  GGTP þ ½E  G ð1Þ
And an equation for the conservation of mass of G protein:
g0 ¼ ½GGDP þ ½GGTP þ ½E  GGDP þ ½E  GGTP þ ½E  G ð2Þ
Simulation of the mass-action model
The parameters used for the simulations in Fig 2 are summarised in S1 Table. For G protein:
GEF interactions, parameters measured for the Ran:RCC1:RanGAP1 system were used [25, 26];
concentrations of Ran and RCC1 were estimated from the PaxDB database [41] scaled by an
estimate of the total concentration of proteins given by [42]; concentrations of nucleotides were
taken from [43]. The irreversible model was generated by setting k7 = 0. (Alternative irreversible
models could be generated by setting any one or more of the reverse reaction rates to zero.)
All simulations were started from steady-state and generated by (deterministic) numerical
integration of the mass-action equations, with the exception of free enzyme concentration [E]
which was calculated from the total mass of enzyme, Eq 1, with:
• e0 = 0.1 during 0 t< 10
• e0 = 1.0 during 10 t< 20
• and free GEF (E) removed from the simulation until e0 = 0.1 during t 20.
The complete implementation can be found in S1 Simulations.
Quasi-steady-state model
Quasi-steady-state solutions for the intermediate enzyme complexes of the GEF mechanism
(Fig 1B) were derived using the framework of [35] (S1 Fig):
½E ¼ K0
K0 þ K1½GGDP þ K2½GGTP
 
e0
½E  GGDP ¼
Kd1 ½GGDP þ Kd2 ½GGTP
K0 þ K1½GGDP þ K2½GGTP
 
e0
½E  GGTP ¼
Kt1½GGDP þ Kt2½GGTP
K0 þ K1½GGDP þ K2½GGTP
 
e0
½E  G ¼ K
g
1 ½GGDP þ Kg2 ½GGTP
K0 þ K1½GGDP þ K2½GGTP
 
e0
where the Kxi and the Ki are summary parameters (deﬁned in S1 Table).
These quasi-steady-state solutions were substituted into the equation for the rate of change
of [GGTP] given in the mass-action model to obtain a quasi-steady-state model for a generic
GEF acting on a generic G protein:
d½GGTP
dt
¼ kfwdð½GGDP  k½GGTPÞe0
K0 þ K1½GGDP þ K2½GGTP
 fGTPase ð3Þ
Activation of G Proteins by GEFs Relies on GTPase Activity
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where kfwd is the product of the forward kinetic rates, and κ is the ratio of the backwards to the
forwards kinetic rates, multiplied by the ratio of GDP to GTP.
This equation does not consider mass held in GEFG protein intermediate complexes and
so is only a good approximation when e0 g0. Note that with fGTPase = 0 this model reduces to
the Michaelis-Menten equation when y = 0, and is equivalent to the equation used by [23]
when the concentration of GTP is absorbed into the summary parameters.
Steady-state ratio of inactive to active G protein
At steady-state with fGTPase = 0, Eq 3 implies:
½GGDP ¼ k½GGTP ð4Þ
Assuming that e0 g0, Eq 2 simplifies to g0 = [GGDP] + [GGTP], into which Eq 4 can be
substituted to obtain:
½GGTP
g0
¼ 1
kþ 1
This is the maximum steady-state proportion of active G protein.
Active G protein as a function of GEF concentration (without GTPase
activity)
The effect of increasing the concentration of GEF on the steady-state concentration of active G
protein in the absence of GTPase activity (fGTPase = 0) was investigated.
The quasi-steady-state solutions for the intermediate enzyme complexes and Eq 4 were
substituted into Eq 2 to obtain:
0 ¼ ðkþ 1Þ½GGTP2 þ 2b½GGTP  Ksg0
where b ¼ 1
2
e0  g0 þ ðkþ 1ÞKsð Þ and Ks ¼ K0ðK1kþK2Þ.
This quadratic equation has one positive solution:
½GGTP ¼
1
kþ 1 bþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b2 þ ðkþ 1ÞKsg0
q 
Alternatively, the proportion of active G protein is:
½GGTP
g0
¼ 1
g0ðkþ 1Þ
bþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b2 þ ðkþ 1ÞKsg0
q 
ð5Þ
We are interested in the rate of change of [GGTP] with respect to e0, the total concentration
of GEF. As b (and only b) is a function of e0, we can examine:
d½GGTP
db
¼ 1
kþ 1
bﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b2 þ ðkþ 1ÞKsg0
p  1
 !
< 0
As this equation is always negative, the concentration of active G protein must decrease as
the concentration of GEF is increased (and vice-versa).
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Active G protein as a function of GEF concentration (with GTPase
activity)
The effect of increasing the concentration of GEF on the steady-state concentration of active G
protein with GTPase activity (fGTPase = kase[GGTP]) was investigated.
At steady-state d½GGTP 
dt
¼ 0 implies:
½GGDP ¼
K2y
2 þ ðK0 þ kk^e0Þ½GGTP
k^e0  K1½GGTP
ð6Þ
where k^ ¼ kfwd
kase
.
Again assuming that e0 g0, Eq 2 simplifies to g0 = [GGDP] + [GGTP], into which Eq 6 can
be substituted to obtain:
0 ¼ ðK2  K1Þ½GGTP2 þ 2b^½GGTP  k^g0e0
where b^ ¼ 1
2
K0 þ K1g0 þ ðkþ 1Þk^e0ð Þ.
This quadratic equation has one solution that lies in the region 0 [GGTP] g0:
½GGTP ¼
1
K2  K1
b^ þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b^2 þ ðK2  K1Þk^g0e0
q 
Alternatively, the proportion of active G protein is:
½GGTP
g0
¼ 1
g0ðK2  K1Þ
b^ þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b^2 þ ðK2  K1Þk^g0e0
q 
ð7Þ
The relative strength of the total forward catalytic activity of the GEF to the GTPase activity
is given by the value of e0k^—though we are restricted by the constraint e0 g0, we remain
unrestrained in k^.
Supporting Information
S1 Fig. Application of the framework of [35] to the mechanism for GEF-mediated exchange
of guanine nucleotides on G proteins. A The graph on the enzyme complexes with complexes
as vertices and edges representing reactions labelled by rates and partner species. B All possible
directed spanning trees of the graph on the enzyme complexes. The red vertex denotes the root
of each spanning tree. C The basis element, ρ, generated from the each spanning trees: the sum
over each root vertex, of the products of the labels of each spanning tree. Every steady-state of
the original system X = ([E], [E  GGDP], [E  GGTP], [E  G])T is a solution to the equation X =
λρ where λ is a constant. We manipulate this equation to obtain Xi ¼ riP
i
ri
PiXi.
(TIFF)
S1 Table. Concentrations, kinetic parameters, and summary parameters used for Figs 2
and 3.
(PDF)
S1 Simulations. Jupyter notebook containing Python code to produce the simulations
shown in Figs 2 and 3.
(IPYNB)
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